Theravance Biopharma, Inc. — Quarterly Financial Statements (NASDAQ:TBPH) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Market Capitalization 921.99 M
Employee 97
Founded 2013
CEO N/A
Website www.theravance.com
Headquarter California, United States
FIGI N/A
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

921.99 M Market capitalization

Price to earnings ratio

25.61

Price to sales ratio

9.15

Dividends per share

—

Dividend yield %

—

Notizie

CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?

Is the Options Market Predicting a Spike in Theravance Biopharma Stock?

Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term

Il titolo Theravance Biopharma raggiunge il massimo di 52 settimane a $21,01

Theravance Biopharma stock hits 52-week high at $21.01

Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term

Il titolo di Theravance Biopharma raggiunge il massimo di 52 settimane a 20,69 USD

Theravance Biopharma stock hits 52-week high at 20.69 USD

Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term

Jefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - BitVentures Limited - Ordinary Share (NASDAQ:BVC), Datavault AI (NASDAQ:DVLT)

Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Aeva Technologies (NASDAQ:AEVA), Alumis (NASDAQ:ALMS)

mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Aimei Health Technology (NASDAQ:AFJK), Comcast (NASDAQ:CMCSA)